{
  "ptid_time": "137_S_0481_2008-06-06",
  "img_path": "/data/qiuhui/data/adni/images/137_S_0481/2008-06-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 53,971 mm³, 14.8% above the reference mean. With a Z-score of 0.43 (66.6th percentile), this represents normal volume ; whole brain volume measures 966,851 mm³, 6.1% below the reference mean. With a Z-score of -0.79 (21.4th percentile), this represents normal volume . ",
  "text_data": "Age is 86.8 years. Gender is Male. Education: 18 years. MMSE: 28.0. Logical Memory: 6.0. Laboratory findings: Thyroid Stim. Hormone: 4.07 (significant elevated); Eosinophils: 0.53 (profound elevated); Eosinophils: 7.00 (profound elevated); Creatinine (Rate Blanked): 1.40 (significant elevated); Urea Nitrogen: 30.00 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 480.20 pg/mL (mild reduced); Total tau: 341.90 pg/mL (mild elevated); Phosphorylated tau: 37.88 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild reductions in whole brain volume (6.1% below mean, Z-score -0.79) but still within the normal range. Biomarkers indicate mild Aβ reduction and significant P-tau elevation, suggestive of early Alzheimer's pathology, but cognitive performance (MMSE 28) remains intact.  \n**Diagnosis:** **MCI** (mild cognitive impairment, likely prodromal Alzheimer's due to biomarker profile)  \n**Confidence:** **Medium** (cognitive scores are preserved, but biomarker and volumetric changes align with early neurodegeneration).  \n\n*Note: Given the MMSE of 28, this could also be classified as **CN (cognitively normal) with Alzheimer's pathology**, but the tau elevation and brain volume loss tilt toward early MCI. Clinical correlation (e.g., subjective complaints, functional assessments) would strengthen confidence.*",
  "timestamp": "2025-07-26T16:12:06.168009"
}